Cynosure Company Profile (NASDAQ:CYNO)

About Cynosure

Cynosure logoCynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Company operates through aesthetic treatment products and services segment. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company's product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CYNO
  • CUSIP: 23257720
Key Metrics:
  • Previous Close: $66.30
  • 50 Day Moving Average: $51.78
  • 200 Day Moving Average: $49.04
  • 52-Week Range: $38.01 - $66.65
  • Trailing P/E Ratio: 102.00
  • Foreward P/E Ratio: 32.50
  • P/E Growth: 1.93
  • Market Cap: $1.57B
  • Outstanding Shares: 23,631,000
  • Beta: 1.65
Profitability:
  • Net Margins: 3.56%
  • Return on Equity: 6.86%
  • Return on Assets: 5.35%
Debt:
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 3.28%
  • Quick Ratio: 2.54%
Additional Links:
Companies Related to Cynosure:

Analyst Ratings

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $57.71 (12.95% downside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
Show:
DateFirmActionRatingPrice TargetDetails
2/16/2017Northland SecuritiesReiterated RatingOutperform$60.00View Rating Details
2/14/2017Northcoast ResearchUpgradeSell -> NeutralView Rating Details
2/14/2017Maxim GroupDowngradeBuy -> Hold$66.00View Rating Details
2/14/2017AegisDowngradeBuy -> HoldView Rating Details
10/28/2016Leerink SwannReiterated RatingOutperform$63.00 -> $60.00View Rating Details
10/26/2016Stifel NicolausReiterated RatingBuy$62.00 -> $58.00View Rating Details
10/24/2016Brean CapitalReiterated RatingBuyView Rating Details
3/6/2015Tigress FinancialInitiated CoverageBuyView Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Cynosure (NASDAQ:CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2017        
2/7/2017Q416$0.41$0.44$119.97 million$122.10 millionViewListenView Earnings Details
10/25/2016Q316$0.28$0.29$101.11 million$106.40 millionViewListenView Earnings Details
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details
2/9/2016Q415$0.38$0.42$95.01 million$102.40 millionViewListenView Earnings Details
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details
7/28/2015Q215$0.29$0.30$82.71 million$83.70 millionViewListenView Earnings Details
5/5/2015Q1$0.09$0.15$70.87 million$74.90 millionViewListenView Earnings Details
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details
7/29/2014Q214$0.29$0.32$71.15 million$72.60 millionViewListenView Earnings Details
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details
10/23/2012$0.12$0.25ViewN/AView Earnings Details
7/24/2012$0.12$0.20ViewN/AView Earnings Details
5/1/2012($0.02)$0.06ViewN/AView Earnings Details
2/14/2012$0.05$0.08ViewN/AView Earnings Details
10/25/2011$0.04($0.06)ViewN/AView Earnings Details
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cynosure (NASDAQ:CYNO)
Current Year EPS Consensus Estimate: $1.56 EPS
Next Year EPS Consensus Estimate: $2.04 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.13$0.26$0.18
Q2 20165$0.27$0.37$0.31
Q3 20165$0.27$0.35$0.31
Q4 20163$0.39$0.43$0.41
Q1 20173$0.23$0.26$0.24
Q2 20173$0.40$0.44$0.43
Q3 20173$0.38$0.42$0.40
Q4 20173$0.51$0.61$0.57
Q1 20181$0.34$0.34$0.34
Q2 20181$0.51$0.51$0.51
Q3 20181$0.50$0.50$0.50
Q4 20181$0.67$0.67$0.67
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cynosure (NASDAQ:CYNO)
Insider Ownership Percentage: 2.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2016Douglas J DelaneyVPSell7,875$45.00$354,375.00View SEC Filing  
11/22/2016Michael R DavinChairmanSell16,284$45.00$732,780.00View SEC Filing  
8/30/2016Brian M BarefootDirectorSell21,000$51.66$1,084,860.00View SEC Filing  
8/15/2016Michael R DavinChairmanSell12,062$53.35$643,507.70View SEC Filing  
8/15/2016Timothy W BakerCFOSell5,834$53.35$311,243.90View SEC Filing  
8/11/2016Michael R DavinChairmanSell4,222$53.18$224,525.96View SEC Filing  
8/11/2016Timothy W BakerCFOSell2,041$53.19$108,560.79View SEC Filing  
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cynosure (NASDAQ:CYNO)
DateHeadline
4-traders.com logoHologic : to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary... (NASDAQ:CYNO)
www.4-traders.com - February 24 at 12:03 PM
marketexclusive.com logoCYNOSURE, INC. (NASDAQ:CYNO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors ... - Market Exclusive (NASDAQ:CYNO)
marketexclusive.com - February 23 at 9:37 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:CYNO)
biz.yahoo.com - February 22 at 9:00 AM
sbwire.com logoAcquisition of Cynosure, Inc. (CYNO) Under Investigation for Investors (NASDAQ:CYNO)
www.sbwire.com - February 21 at 5:56 PM
4-traders.com logoCynosure : Acquisition of Cynosure, Inc. (CYNO) Under Investigation for Investors (NASDAQ:CYNO)
www.4-traders.com - February 21 at 5:56 PM
News IconHologic Acquires Cynosure Amid Medical Esthetic Market Shift (NASDAQ:CYNO)
www.skininc.com - February 20 at 11:35 AM
News IconShares Worth Watching: Cynosure, Inc. (NASDAQ:CYNO) - Rockville Register (NASDAQ:CYNO)
rockvilleregister.com - February 19 at 4:19 PM
businesswire.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic ... - Business Wire (press release) (NASDAQ:CYNO)
www.businesswire.com - February 18 at 8:08 AM
rttnews.com logoCynosure Inc. (CYNO) Leaped To A New High After Purchased By Hologic (NASDAQ:CYNO)
www.rttnews.com - February 16 at 7:01 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 7:01 PM
News IconCynosure settles unwanted fax class action for $16 million - Legal News Line (NASDAQ:CYNO)
legalnewsline.com - February 16 at 2:00 PM
finance.yahoo.com logoCYNOSURE (CYNO) Alert: Johnson & Weaver, LLP Launches an ... - Yahoo Finance (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 2:00 PM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An ... - Business Wire (press release) (NASDAQ:CYNO)
www.businesswire.com - February 16 at 2:00 PM
fool.com logoHere's Why Cynosure, Inc. is Soaring Today - Motley Fool (NASDAQ:CYNO)
www.fool.com - February 16 at 2:00 PM
finance.yahoo.com logoCynosure (CYNO) to be Acquired by Hologic in $1.65B Deal (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 2:00 PM
investopedia.com logoHologic to Acquire Cynosure for $1.65 Billion (NASDAQ:CYNO)
www.investopedia.com - February 16 at 2:00 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 2:00 PM
finance.yahoo.com logoHarwood Feffer LLP Announces Investigation of Cynosure, Inc. (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 2:00 PM
finance.yahoo.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic, Inc. May be Unfair to Shareholders (NASDAQ:CYNO)
finance.yahoo.com - February 16 at 2:00 PM
News IconAcquisitions in aesthetics space continuewith $1.65B proposed buy of Cynosure (NASDAQ:CYNO)
medicaldevicedaily.com - February 14 at 10:28 PM
News IconCynosure, Inc. To Be Acquired By Hologic For $1.65 Billion (NASDAQ:CYNO)
latribunadecanarias.com - February 14 at 10:28 PM
marketexclusive.com logoCYNOSURE, INC. (NASDAQ:CYNO) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:CYNO)
marketexclusive.com - February 14 at 10:28 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws (NASDAQ:CYNO)
biz.yahoo.com - February 14 at 10:27 PM
finance.yahoo.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout (NASDAQ:CYNO)
finance.yahoo.com - February 14 at 10:27 PM
News IconHologic to buy Cynosure in $1.65B deal (NASDAQ:CYNO)
www.massdevice.com - February 14 at 5:26 PM
wsj.com logoCynosure Inc. Cl A (NASDAQ:CYNO)
quotes.wsj.com - February 14 at 5:26 PM
News IconCynosure, Inc. To Be Acquired By Hologic, Inc. For $66/Share In Cash, Or $1.65 Bln (NASDAQ:CYNO)
www.talkmarkets.com - February 14 at 5:26 PM
finance.yahoo.com logoHologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and ... (NASDAQ:CYNO)
finance.yahoo.com - February 14 at 5:26 PM
nasdaq.com logoCynosure Inc. (CYNO) Has Jumped To A New High After Bought By Hologic (NASDAQ:CYNO)
www.nasdaq.com - February 14 at 5:25 PM
marketwatch.com logoCynosure's stock rockets after buyout deal with Hologic (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Cynosure, Inc. for $66 Per Share is Fair to Shareholders - CYNO (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
bizjournals.com logoHologic will snap up Westford-based Cynosure in $1.65B deal (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
us.rd.yahoo.com logoHologic to buy Cynosure to expand into medical aesthetics (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
fool.com logoHere's Why Cynosure, Inc. is Soaring Today (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
capitalcube.com logoETFs with exposure to Cynosure, Inc. : February 14, 2017 (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
fool.com logoWhy Cynosure, RetailMeNot, and TransUnion Jumped Today (NASDAQ:CYNO)
us.rd.yahoo.com - February 14 at 5:25 PM
sg.finance.yahoo.com logoDr Pepper Snapple and Popeyes sink; General Motors leaps (NASDAQ:CYNO)
sg.finance.yahoo.com - February 14 at 5:25 PM
fool.com logoHere's Why Cynosure, Inc. is Soaring Today (NASDAQ:CYNO)
www.fool.com - February 14 at 12:15 PM
feeds.benzinga.com logoInMode Aesthetics Strengthens Sales Force in North America (NASDAQ:CYNO)
feeds.benzinga.com - February 14 at 11:13 AM
sbwire.com logoCosmetic Procedures and Products Market: Emergence of Advanced Technologies and Global Industry Analysis 2024 (NASDAQ:CYNO)
www.sbwire.com - February 13 at 5:20 PM
openpr.com logoCosmetic Procedures And Products Market : Analysis Of Market Trends & Technological Improvements (NASDAQ:CYNO)
www.openpr.com - February 11 at 3:04 AM
prnewswire.com logoSurgical Lasers Market by product type, Procedure, & Application - Global forecast to 2021 (NASDAQ:CYNO)
www.prnewswire.com - February 10 at 3:16 AM
News IconLarge Buying Action and Inflow of Money Witnessed in Cynosure, Inc. - Highland Mirror (NASDAQ:CYNO)
www.highlandmirror.com - February 9 at 5:08 PM
gurufocus.com logoAmerican Capital Management Inc Buys Tivity Health, Cynosure, Gigamon, Sells Cepheid, FleetMatics Group PLC ... - GuruFocus.com (NASDAQ:CYNO)
www.gurufocus.com - February 9 at 5:08 PM
capitalcube.com logoCynosure, Inc. :CYNO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017 (NASDAQ:CYNO)
www.capitalcube.com - February 9 at 5:08 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:CYNO)
us.rd.yahoo.com - February 8 at 5:05 PM
capitalcube.com logoCynosure, Inc. :CYNO-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 (NASDAQ:CYNO)
www.capitalcube.com - February 8 at 5:05 PM
finance.yahoo.com logoEdited Transcript of CYNO earnings conference call or presentation 7-Feb-17 2:00pm GMT (NASDAQ:CYNO)
finance.yahoo.com - February 7 at 10:47 PM
seekingalpha.com logoCynosure, Inc. 2016 Q4 - Results - Earnings Call Slides (NASDAQ:CYNO)
seekingalpha.com - February 7 at 5:47 PM
biz.yahoo.com logoQ4 2016 Cynosure Inc Earnings Release - Before Market Open (NASDAQ:CYNO)
us.rd.yahoo.com - February 7 at 5:47 PM

Social

What is Cynosure's stock symbol?

Cynosure trades on the NASDAQ under the ticker symbol "CYNO."

Where is Cynosure's stock going? Where will Cynosure's stock price be in 2017?

7 analysts have issued 12-month price targets for Cynosure's shares. Their forecasts range from $40.00 to $66.00. On average, they expect Cynosure's share price to reach $57.71 in the next twelve months.

When will Cynosure announce their earnings?

Cynosure is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Cynosure stock?

Here are some recent quotes from research analysts about Cynosure stock:

  • According to Zacks Investment Research, "Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products incorporate a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. " (1/9/2017)

  • Brean Capital analysts commented, "Centene reported 1Q16 results this morning and put to bed most concerns regarding the Health Net acquisition that closed in late March. Revenue was about $7 billion, in line with our estimate after reflecting the delayed close of the Health Net acquisition. Importantly, the company’s individual exchange business appears to be performing nicely. Health Net’s individual exchange business does not appear to be problematic. The company wrote off Health Net’s outstanding receivables (relating to the 3Rs) and will record balance sheet adjustments to Health Net’s days in claims payables in 2Q16. On the surface, it appears as though Centene has its hands firmly around the acquisition. CNC shares remain very attractive and offer 35% upside potential to our price target (even after reflecting today’s strength in the share price)." (4/27/2016)

Who owns Cynosure stock?

Cynosure's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock, Inc (12.00%), Dimensional Fund Advisors LP (5.10%), Loomis Sayles & Co. L P (2.66%), State Street Corp (2.52%), Disciplined Growth Investors Inc. MN (1.47%) and Russell Investments Group Ltd. (1.32%). Company insiders that own Cynosure stock include Brian M Barefoot, Douglas J Delaney, Ettore V Biagioni, Michael R Davin and Timothy W Baker.

Who sold Cynosure stock? Who is selling Cynosure stock?

Cynosure's stock was sold by a variety of institutional investors in the last quarter, including Numeric Investors LLC, Two Sigma Investments LP, Allianz Asset Management AG, GSA Capital Partners LLP, Thompson Siegel & Walmsley LLC, AQR Capital Management LLC, Loomis Sayles & Co. L P and Frontier Capital Management Co. LLC. Company insiders that have sold Cynosure stock in the last year include Brian M Barefoot, Douglas J Delaney, Michael R Davin and Timothy W Baker.

Who bought Cynosure stock? Who is buying Cynosure stock?

Cynosure's stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Newtyn Management LLC, Disciplined Growth Investors Inc. MN, Dimensional Fund Advisors LP, State Street Corp, ING Groep NV, Micawber Capital LLC and Menta Capital LLC.

How do I buy Cynosure stock?

Shares of Cynosure can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cynosure stock cost?

One share of Cynosure stock can currently be purchased for approximately $66.30.

Cynosure (NASDAQ:CYNO) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cynosure (NASDAQ:CYNO)

Earnings History Chart

Earnings by Quarter for Cynosure (NASDAQ:CYNO)

Dividend History Chart

Dividend Payments by Quarter for Cynosure (NASDAQ:CYNO)

Last Updated on 2/24/2017 by MarketBeat.com Staff